We find that G9a mediates the repressive transcriptional activity of MYCN in repressing neuronal differentiation genes in NB, and this led to a strategy that simultaneous inhibition of both WDR5 and G9a would more fully target MYCN oncogenic transcriptional activities. The gene discussed is WDR5; the disease is neuroblastoma.